Metric,Value
Total Trials (Full Dataset),"10,000"
Test Set Trials,"2,000"
Completed Trials,"7,911"
Terminated Trials,"2,089"
Completion Rate,79.1%
Average Enrollment,228
Median Enrollment,49
Phase 1 Count,0
Phase 2 Count,"2,318"
Phase 3 Count,"2,706"
